Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bromhexine hydrochloride for prevention of COVID-19 disease
IRCT20200317046797N7Phase 2Completed
- Sponsor
- Tabriz University of Medical Sciences
- Start
- Apr 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of bromhexine in coronavirus disease 2019 (COVID-19), sponsored by Tabriz University of Medical Sciences. Started Apr 2020; status: completed.
02
Drugs
bromhexine
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on IRCT20200317046797N7.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200317046797N7.